miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2

Zeinab Mohamed(Hokkaido University), Hidemichi Watari(Hokkaido University)
Oncotarget
July 10, 2018
Cited by 31


Related Papers